Cited by 223Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Clinical Subtypes of Alzheimer’s Disease

Petersen, R.C.·1998·Dementia and Geriatric Cognitive Disorders

DOI 10.1159/000051199

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) can present as a variety of clinical profiles. Although the most common presentation is that of a progressive amnestic disorder with subsequent involvement of other cognitive functions and personality alterations, there are numerous other clinical profiles. AD can present as a focal cortical degenerative syndrome with the clinical features dependent on the regions of the brain involved. Some of these syndromes include disturbances of language, visuospatial skills, attentional functions, executive processes and praxis. The neuropathological substrate of these disorders is variable and can include AD. Recently, the Lewy body variant of AD has been described. Finally, other modifying features that affect the progression of AD, such as extrapyramidal symptoms and myoclonus, are also discussed. Although the progressive amnestic form of AD is the most common presentation, other variations on the clinical syndrome can be important to identify because they may have implications for prognosis and treatment.

Integrity signals

Registry

Crossref · 10.1159/000051199

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Primary Progressive Aphasia
Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,018
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Slowly progressive aphasia without generalized dementia
Mesulam, M. (1982) · Annals of Neurology · doi:10.1002/ana.410110607 · Cited by 1,241
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128
Self-citation
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
Jack, C. R., Petersen, R. C., O’Brien, P. C., & Tangalos, E. G. (1992) · Neurology · doi:10.1212/wnl.42.1.183 · Cited by 880
Self-citation
Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological Measures
Welsh-Bohmer, K. A., Butters, N., Hughes, J. P., Mohs, R. C., & Heyman, A. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530150046016 · Cited by 721
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S.-H., & Aronson, M. K. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90027-u · Cited by 643

Flagged first, then by citations

Show all 57 references

Sorted by citations

Items 101–200 of 223

Coronary Artery Calcification Progression Is Associated with Arterial Stiffness and Cardiac Repolarization Deterioration in Hemodialysis Patients
Iorio, B. R. D., Nargi, O., Cucciniello, E., Bellizzi, V., Torraca, S., Russo, D., Bellasi, A., & on behalf of the INDEPENDENT study investigators (2011) · Kidney & Blood Pressure Research · doi:10.1159/000325656 · Cited by 45
Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.
Marshall, M., Vandal, A., de Zoysa, J., Gabriel, R., Haloob, I., Hood, C. J., Irvine, J. H., Matheson, P. J., Mcgregor, D. O., Rabindranath, K., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019090877 · Cited by 34
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study
RENAAL Investigators, Boner, G., Cooper, M. E., McCarroll, K., Brenner, B. M., de Zeeuw, D., Kowey, P. R., Shahinfar, S., Dickson, T. Z., Crow, R. S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1893-1 · Cited by 44
Visceral fat and coronary artery calcification in patients with chronic kidney disease
Cordeiro, A. C., Qureshi, A. R., Lindholm, B., Amparo, F. C., Tito-Paladino-Filho, A., Perini, M., Lourenco, F. S., Pinto, I. M. F., Amodeo, C., & Carrero, J. J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft250 · Cited by 43
Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients
Choi, H. Y., Lee, J. E., Han, S. H., Yoo, T., Kim, B. S., Park, H. C., Kang, S., Choi, K. H., Ha, S. K., Lee, H. Y., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp598 · Cited by 43
Type 1 Diabetes Increases the Expression of Proinflammatory Cytokines and Adhesion Molecules in the Artery Wall of Candidate Patients for Kidney Transplantation
Triñanes, J., SALIDO, E. C., Fernández, J., Rufino, M., González‐Posada, J. M., Torres, A., & Hernández, D. (2011) · Diabetes Care · doi:10.2337/dc11-1665 · Cited by 43
Reciprocal Association of Plasma Adiponectin and Serum C-Reactive Protein Concentration in Haemodialysis Patients with End-Stage Kidney Disease – A Follow-Up Study
Ignacy, W., Chudek, J. T., Adamczak, M., Funahashi, T., Matsuzawa, Y., Kokot, F., & Więcek, A. (2005) · Nephron Clinical Practice · doi:10.1159/000085707 · Cited by 42
Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation
Rubinger, D., Backenroth, R., & Sapoznikov, D. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn732 · Cited by 40
Subgroups of Alzheimer's Disease: Stability of Empirical Clusters Over Time
Peter, J., Initiative, A. D. N., Abdulkadir, A., Kaller, C. P., Kümmerer, D., Hüll, M., Vach, W., & Klöppel, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140261 · Cited by 40
Cognitive screening and neuropsychological assessment in early alzheimer's disease
Salmon, D. P., & Lange, K. L. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70067-7 · Cited by 39
α-Synuclein, Aβ and Alzheimer's disease
Wirths, O. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00339-1 · Cited by 37
Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients
Jung, H. H., R., K., & Han, H. S. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh488 · Cited by 38
Reproducibility of methods for assessing baroreflex sensitivity and temporal QT variability in end-stage renal disease and healthy subjects
Gao, S. A., Johansson, M., Hammar�n, A., Nordberg, M. E., & Friberg, P. (2005) · Clinical Autonomic Research · doi:10.1007/s10286-005-0224-4 · Cited by 36
Endothelial Progenitor Cells in Chronic Renal Insufficiency
Herbrig, K., Pistrosch, F., Foerster, S., & Gross, P. A. (2006) · Kidney & Blood Pressure Research · doi:10.1159/000092484 · Cited by 36
Kidney Function and Use of Recommended Medications after Myocardial Infarction in Elderly Patients
Winkelmayer, W. C., Charytan, D. M., Brookhart, M. A., Levin, R., Solomon, D. H., & Avorn, J. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00150106 · Cited by 35
Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232]
the MASTERPLAN study group, van Zuilen, A. D., van der Tweel, I., Blankestijn, P. J., Bots, M. L., van Buren, M., ten Dam, M. A. G. J., Kaasjager, K. A. H., van de Ven, P. J. G., Vervoort, G., et al. (2006) · Trials · doi:10.1186/1745-6215-7-8 · Cited by 34
CYP2C9 and ABCG2 Polymorphisms as Risk Factors for Developing Adverse Drug Reactions in Renal Transplant Patients Taking Fluvastatin: A Case–Control Study
Skvrce, N. M., Božina, N., Zibar, L., Barišić, I., Ganoci, L., & Šarinić, V. M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.135 · Cited by 35
Endothelial Progenitor Cells in Kidney Transplant Recipients
Steiner, S., Winkelmayer, W. C., Kleinert, J., Grisar, J. C., Seidinger, D., Kopp, C. W., Watschinger, B., Minar, E., rl, W. H. H., dinger, M. F., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000198418.06383.e8 · Cited by 35
PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats
Phan, O., Maillard, M. P., Perregaux, C., Mordasini, D., Stehle, J., Funk, F., & Burnier, M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204792 · Cited by 32
Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients
Singer, J. B., Holdaas, H., Jardine, A. G., Fellström, B., Os, I., Bermann, G., & Meyer, J. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700076-jlr200 · Cited by 32
The relation of aphasia to dementia
Au, R., Albert, M. L., & Obler, L. K. (1988) · Aphasiology · doi:10.1080/02687038808248901 · Cited by 32
Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
Johnson, C., Prokopienko, A. J., West, R. E., Nolin, T. D., & Stubbs, J. R. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081646 · Cited by 31
Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease
van Guldener, C., Nanayakkara, P. W. B., & Stehouwer, C. D. A. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.340 · Cited by 31
Bone Mineral Density in End-Stage Renal Disease Patients: Association with Wasting, Cardiovascular Disease and Mortality
Matsubara, K., Suliman, M. E., Qureshi, A. R., Axelsson, J., Martola, L., Heimbürger, O., Barany, P. F., Stenvinkel, P., & Lindholm, B. (2008) · Blood Purification · doi:10.1159/000126925 · Cited by 30
Nitric oxide in chronic renal failure
Passauer, J., Pistrosch, F., & Büssemaker, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00259.x · Cited by 30
Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis
Kauffmann, M., Bobot, M., Robert, T., Burtey, S., Couvrat-Desvergnes, G., Lavainne, F., Puéchal, X., Terrier, B., Quéméneur, T., Faguer, S., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03190321 · Cited by 28
Visceral Fat Thickness Is Associated With Carotid Atherosclerosis in Peritoneal Dialysis Patients
Lee, M. J., Shin, D., Kim, S. J., Oh, H. J., Yoo, D. E., Kim, J., Park, J. T., Han, S. H., Kang, S., Choi, K. H., et al. (2011) · Obesity · doi:10.1038/oby.2011.245 · Cited by 27
Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis
Han, S. H., Kang, E. W., Yoon, S., Yoon, H. S., Lee, H. C., Yoo, T., Choi, K. H., Han, D.-I., & Kang, S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr108 · Cited by 26
Elevated Serum 8-Oxo-dG in Hemodialysis Patients: A Marker of Systemic Inflammation?
Haghdoost, S., Maruyama, Y., Pecoits‐Filho, R., Heimbürger, O., Seeberger, A., Anderstam, B., Suliman, M. E., Czene, S., Lindholm, B., & Stenvinkel, P. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2169 · Cited by 27
Development of a Questionnaire on Everyday Navigational Ability to Assess Topographical Disorientation in Alzheimer’s Disease
Pai, M., Lee, C., Yang, Y.-C., Lee, Y.-T., Chen, K.-C., Lin, S.-H., Jheng, S.-S., Sun, P.-W., & Cheng, P.-J. (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512436805 · Cited by 26
Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure
Filsoufi, F., Chikwe, J., Castillo, J. G., Rahmanian, P. B., Vassalotti, J. A., & Adams, D. H. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn337 · Cited by 26
Progressive impairment of constructional abilities: a visuospatial sketchpad deficit?
Papagno, C. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00072-6 · Cited by 26
Strategies to decrease cardiovascular mortality in patients with end-stage renal disease
Dikow, R., Adamczak, M., Henriquez, D. E., & Ritz, E. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.3.x · Cited by 26
Prospective trials on anemia of chronic disease: The Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT)
Rao, M., & Pereira, B. J. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s87.21.x · Cited by 26
The Great East Japan Earthquake: Blood Pressure Control in Patients With Chronic Kidney Disease
Tanaka, K., Nakayama, M., Tani, Y., Watanabe, K., Asai, J., Hayashi, Y., Asahi, K., & Watanabe, T. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.71 · Cited by 25
Pulse Wave Velocity Is Associated with Metabolic Syndrome Components in CAPD Patients
Zhe, X., Zeng, J., Tian, X.-K., Chen, W., Gu, Y., Cheng, L.-T., Chen, H., Axelsson, J., Lindholm, B., & Wang, T. (2008) · American Journal of Nephrology · doi:10.1159/000117813 · Cited by 25
A descriptive study on constructional impairment in frontotemporal dementia and Alzheimer’s disease
Gasparini, M., Masciarelli, G., Vanacore, N., Ottaviani, D., Salati, E., Talarico, G., Lenzi, G. L., & Bruno, G. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02128.x · Cited by 24
The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: Rationale and study design of a randomized controlled pilot study
Walsh, M. W., Manns, B., Klarenbach, S. W., Quinn, R. R., Tonelli, M. A., & Culleton, B. F. (2006) · BMC Nephrology · doi:10.1186/1471-2369-7-2 · Cited by 24
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD
Kimber, C., Zhang, S., Johnson, C., West, R. E., Prokopienko, A. J., Mahnken, J. D., Yu, A. S. L., Hoofnagle, A. N., Ir, D., Robertson, C. E., et al. (2020) · Kidney360 · doi:10.34067/kid.0003942020 · Cited by 23
Cardiovascular Outcomes Reported in Hemodialysis Trials
O’Lone, E., Viecelli, A. K., Craig, J. C., Tong, A., Sautenet, B., Roy, D. A., Herrington, W. G., Herzog, C. A., Jafar, T. H., Jardine, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.012 · Cited by 24
ARTERIAL CALCIFICATION AND STIFFNESS IN CHRONIC KIDNEY DISEASE
Pg, K., & Guerin, A. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04660.x · Cited by 22
Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders
Behets, G. J. S., Dams, G., Damment, S. J. P., Martin, P. T., Broe, M. E. D., & D’Haese, P. C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00219.2013 · Cited by 22
Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
Vanholder, R. C., Laecke, S. V., Verbeke, F., Glorieux, G., & Biesen, W. V. (2007) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfm024 · Cited by 22
Short-Term Effects of Very-Low-Phosphate and Low-Phosphate Diets on Fibroblast Growth Factor 23 in Hemodialysis Patients
Tsai, W., Wu, H., Peng, Y., Hsu, S., Chiu, Y., Yang, J., Chen, H., Pai, M., Lin, W., Hung, K., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04250419 · Cited by 21
Practical Approaches to Management of Hyperphosphatemia: Can We Improve the Current Situation?
Kuhlmann, M. K. (2006) · Blood Purification · doi:10.1159/000096410 · Cited by 21
Systems biology to battle vascular disease
Dominiczak, A. F., Herget‐Rosenthal, S., Delles, C., Fliser, D., Fournier, I., Graber, A., Girolami, M., Holmes, E. C., Lang, F. J. W., Molina, F., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq025 · Cited by 21
Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease
Parnham, S., Gleadle, J., Bangalore, S., Grover, S., Perry, R., Woodman, R. J., Pasquale, C. G. D., & Selvanayagam, J. B. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002249 · Cited by 20
Nitric oxide– and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9
Passauer, J., Pistrosch, F., Lässig, G., Herbrig, K., Büssemaker, E., Gross, P. A., & Fleming, I. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00289.x · Cited by 20
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy
Krieter, D. H., Fischer, R., Merget, K., Lemke, H., Morgenroth, A., Canaud, B., & Wanner, C. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq552 · Cited by 19
Association of Smoking with Cardiovascular and Infection-Related Morbidity and Mortality in Chronic Hemodialysis
Causland, F. R. M., Brunelli, S. M., & Waikar, S. S. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03880412 · Cited by 18
Elevated temporal QT variability index in patients with chronic renal failure
Johansson, M., Gao, S. A., Friberg, P., Annerstedt, M., Bergström, G. M. L., Carlström, J., Ivarsson, T., Jensen, G., Ljungman, S., Mathillas, O., et al. (2004) · Clinical Science · doi:10.1042/cs20040122 · Cited by 17
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering
Paraskevas, K. I. (2007) · International Urology and Nephrology · doi:10.1007/s11255-007-9307-6 · Cited by 17
Visual perception without awareness in a patient with posterior cortical atrophy: Impaired explicit but not implicit processing of global information
Filoteo, J. V., Friedrich, F. J., Rabbel, C. D., & Stricker, J. L. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s135561770281325x · Cited by 16
Glomerular Filtration Rate on Admission Independently Predicts Short-Term In-Hospital Mortality after Acute Myocardial Infarction
Afshinnia, F., Ayazi, P., & Chadow, H. L. (2006) · American Journal of Nephrology · doi:10.1159/000095301 · Cited by 15
Positive CSF HSV PCR in patients with GBM: A note of caution
McDermott, S., McDermott, P. F., Skare, J. C., Glantz, M., Smith, T. W., Litofsky, N. S., & Recht, L. D. (2000) · Neurology · doi:10.1212/wnl.54.3.746 · Cited by 15
Homocysteine Lowering in End-Stage Renal Disease
de Koning, L., & Hu, F. B. (2010) · Circulation · doi:10.1161/cir.0b013e3181daa7c9 · Cited by 15
Slope analysis of blood volume and calf bioimpedance monitoring in hemodialysis patients
Seibert, E., Zhu, F., Kuhlmann, M. K., Henson, R., Oribello, A. M., Girndt, M., Kotanko, P., & Levin, N. W. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr734 · Cited by 14
Chronic Renal Failure, Hemodialysis, and Electroconvulsive Therapy
Williams, S., & Ostroff, R. B. (2005) · Journal of Ect · doi:10.1097/01.yct.0000156404.61098.5b · Cited by 14
Molecular Evaluation of Circulating Endothelial Progenitor Cells in Children Undergoing Hemodialysis and After Kidney Transplantation
Metsuyanim, S., Levy, R., Davidovits, M., & Dekel, B. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181903909 · Cited by 14
Physiological monitoring and control in hemodialysis: state of the art and outlook
Kraemer, M. (2006) · Expert Review of Medical Devices · doi:10.1586/17434440.3.5.617 · Cited by 13
Nonhypotensive dose of β-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure
Amann, K., Hofstetter, J., Câmpean, V., Koch, A., Groß, M.-L., Veelken, R. A., & Ritz, E. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0219-0 · Cited by 13
Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure
Kohlhagen, J., & Kelly, J. J. (2003) · Nephrology · doi:10.1111/j.1440-1797.2003.00212.x · Cited by 13
Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT
Perkiömäki, J. S., Ruwald, A., Kutyifa, V., Ruwald, M. H., McNitt, S. A., Polonsky, B., Goldstein, R. E., Haigney, M. C., Krone, R. J., Zaręba, W., et al. (2015) · EP Europace · doi:10.1093/europace/euv201 · Cited by 12
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Management of Heart Failure and Coronary Artery Disease in Patients with Chronic Kidney Disease
Murphy, S. W. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16033.x · Cited by 12
The Uremic Myocardium and Ischemic Tolerance
Dikow, R., & Hardt, S. E. (2012) · Circulation · doi:10.1161/circulationaha.112.093047 · Cited by 12
Recent advances in understanding Alzheimer’s Disease: diagnosis and management strategies
Marín, A., & Budson, A. E. (2023) · Faculty Reviews · doi:10.12703/r/12-24 · Cited by 12
Relationship between the Degree of Malnutrition and Echocardiographic Parameters in Hemodialysis Patients
Kürşat, S., Tekçe, H., Ekmekçi, C., Çolak, H., & Alıcı, T. (2007) · Nephron Clinical Practice · doi:10.1159/000103001 · Cited by 11
Raynaud’s Phenomenon and Endothelial Dysfunction in End-Stage Renal Disease Patients Treated with Hemodialysis
Czupryniak, A., Kałużyńska, A., Nowicki, M. P., Więcek, B., Bald, E., & Owczarek, D. (2004) · Kidney & Blood Pressure Research · doi:10.1159/000081059 · Cited by 11
Independent Risk Factors for Progression of Coronary Atherosclerosis in Hemodialysis Patients
Hase, H., Joki, N., Ishikawa, H., Saijyo, T., Tanaka, Y., Takahashi, Y., Inishi, Y., Imamura, Y., Nakamura, M., & Moroi, M. (2006) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2006.00384.x · Cited by 11
Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease
Peña‐Bautista, C., Álvarez‐Sánchez, L., García‐Lluch, G., Raga, L., Quevedo, P., Peretó, M., Balaguer, Á., Baquero, M., & Cháfer‐Pericás, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105317 · Cited by 10
Protein-Energy Malnutrition
Kalantar‐Zadeh, K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-032-4_11 · Cited by 10
Cardiac Troponin T in Patients With Kidney Disease
Hojs, R. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1774-9987.2005.00254.x · Cited by 10
Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease
Smith, C. D., Chebrolu, H., Markesbery, W. R., & Liu, J. (2008) · Neurological Research · doi:10.1179/174313208x327973 · Cited by 10
Biomedical imaging research opportunities workshop IV: A white paper
Hendee, W. R., Banovac, F., Carson, P. L., DeFronzo, R. A., Eckelman, W. C., Fullerton, G. D., Larson, S. M., McLennan, G., & Welch, M. J. (2007) · Medical Physics · doi:10.1118/1.2405838 · Cited by 10
Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
Reddy, J. S., Jin, J., Lincoln, S., Ho, C. C. G., Crook, J. E., Wang, X., Malphrus, K. G., Nguyen, T., Tamvaka, N., Greig‐Custo, M. T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103929 · Cited by 9
Association between zinc deficiency and aorta stiffness in non-diabetic hemodialysis patients
Ishioka, K., Hidaka, S., Fujiwara, N., Yamano, M., Mochida, Y., Oka, M., Maesato, K., Moriya, H., Ohtake, T., & Kobayashi, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0268875 · Cited by 9
Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency
Briganti, E. M., Kerr, P. G., Shaw, J. E., Zimmet, P., & Atkins, R. C. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00357.x · Cited by 9
The Aged Dog as a Natural Model of Alzheimer’s Disease Progression
Araujo, J. A., Baulk, J., & de Rivera, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53219-6_4 · Cited by 9
Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz
H. Reinecke (Schriftführer), V. B., & Breithardt, G. (2006) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-006-0013-1 · Cited by 8
Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function
Ristiniemi, N., Savage, C., Bruun, L., Pettersson, K. S. I., Lilja, H. G., & Christensson, A. G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr350 · Cited by 8
Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism
Wolf, S. C., Sauter, G., Rodemann, H. P., Risler, T., & Brehm, B. R. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh606 · Cited by 8
Does Timing of Dialysis in Patients with ESRD and Acute Myocardial Infarcts Affect Morbidity or Mortality?
Coritsidis, G., Sutariya, D., Stern, A. S., Gupta, G., Carvounis, C. P., Arora, R., Balmir, S., & Acharya, A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04470908 · Cited by 8
Blood Pressure Control before and after Starting Dialysis
Dasgupta, I., & Burden, R. (2005) · Nephron Clinical Practice · doi:10.1159/000083419 · Cited by 8
Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz
Holger Reinecke (Schriftführer), V. B., & Breithardt, G. (2006) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-006-0011-3 · Cited by 8
New Onset Diabetes Mellitus after Transplant: The Challenge Continues
Aziz, F. (2021) · Kidney360 · doi:10.34067/kid.0004042021 · Cited by 7
rHuEPO Dose Inversely Correlated with the Number of Circulating CD34+ Cells in Maintenance Hemodialysis Patients
Kohagura, K., Ohya, Y., Miyagi, S., Ishida, A., Yakabi, S., Iseki, K., Yamane, N., & Takishita, S. (2007) · Nephron Clinical Practice · doi:10.1159/000112528 · Cited by 6
The utility of naming tests in the diagnosis of Alzheimer's disease
Coen, R. F., Kidd, N., Denihan, A., Cunningham, C. J., Bruce, I., Buggy, F., O’Neill, D. J., Walsh, J. B., Coakley, D., & LAWLOR, B. A. (1999) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700005139 · Cited by 6
Diabetic Patients Can Do as Well on Peritoneal Dialysis as Nondiabetic Patients
Tang, W., Cheng, L.-T., & Wang, T. (2005) · Blood Purification · doi:10.1159/000087771 · Cited by 6
Niereninsuffizienz und kardiovaskuläre Erkrankungen
Weidtmann, B., & Schunkert, H. (2007) · Der Internist · doi:10.1007/s00108-007-1901-2 · Cited by 6
Predicting cardiovascular risk
Chapleau, M. W. (2005) · Clinical Autonomic Research · doi:10.1007/s10286-005-0256-9 · Cited by 5
The «Protocole d’Examen Cognitif de la Personne Agée – Lausanne» (PECPA-L): A Cognitive Assessment Tool for the French-Speaking Elderly in Switzerland
von Gunten, A., Brull, J., Küng, A., Simms, K., Taillefer, D., Geneau, D., & Duc, R. (2006) · European Neurology · doi:10.1159/000091422 · Cited by 5
Screening for Proteinuria
Anderson, A. H. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070730 · Cited by 4
Changes in hemoglobin and albumin concentration during nocturnal home hemodialysis
Agar, J. W. M., & Pierratos, A. (2007) · Hemodialysis International · doi:10.1111/j.1542-4758.2007.00184.x · Cited by 4
Cachexia in Chronic Kidney Disease: Malnutrition-Inflammation Complex and Reverse Epidemiology
Kalantar‐Zadeh, K., & Kopple, J. D. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_31 · Cited by 3
Diabetes, the kidney and vascular disease: a complex relationship
Krentz, A. J. (2006) · Practical Diabetes · doi:10.1002/pdi.878 · Cited by 3
Left ventricular hypertrophy: a surrogate end point or correlate of cardiovascular events in kidney disease?
Griffith, T. F., Reddan, D. N., Klassen, P., & Owen, W. F. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg332 · Cited by 3
If Oxidative Stress Is an Appropriate and Specific Target, What Reagent Should We Choose?
Kaysen, G. A., & Chin, A. I. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111178 · Cited by 3
Identification and Validation of New Molecular Subtypes within the Early and Late Mild Cognitive Impairment Stages of Alzheimer’s DiseasePreprint
Li, B., Yadav, S., Zhou, S. W., Du, Y., Qian, L., Karas, Z., Zhang, Y., Shen, L., Lee, J. J., Vardarajan, B. N., et al. (2023) · medRxiv · doi:10.1101/2023.04.06.23288268 · Cited by 3
Clinical modifiers for heart failure following myocardial infarction
Anavekar, N. S., & Anavekar, N. S. (2005) · Current Heart Failure Reports · doi:10.1007/bf02696646 · Cited by 2
Editorials: A Cautionary Note for Nephrologists: Is It Time to Abandon the Use of Dihydropyridine Calcium Channel Blockers?
Jafar, T. H., & Pereira, B. J. G. (1999) · Seminars in Dialysis · doi:10.1046/j.1525-139x.1999.99008.x · Cited by 2

Authors: Petersen, R. C.
Affiliations: Mayo Clinic (US)
Corresponding author: Petersen, R.C.
ORCID: Petersen, R.C.
Venue: Dementia and Geriatric Cognitive Disorders
Publisher: S. Karger AG
Published: 1998
Volume: 9
Issue: Suppl. 3
Pages: 16-24
ISSN: 1420-8008 (ISSN-L)
1421-9824
DOI: 10.1159/000051199
OpenAlex: W1982494036
Cited by: 223
References: 57
Citations by year: 2024: 1 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 4 · 2013: 13 · 2012: 9
FWCI: 1.75
Type: journal article
Language: en
Open access: closed
Licence: www.karger.com/Services/SiteLicenses (vor)
www.karger.com/Services/SiteLicenses (tdm)
Locations: Dementia and Geriatric Cognitive Disorders (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns029059-03)
National Institute on Aging (AG-08031, P30AG008031, AG-06786, U01AG006786)
National Institute of Neurological Disorders and Stroke (NS 29059)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: Alzheimer's disease, clinical subtypes, language disorders, visuospatial impairment, attentional dysfunction, executive dysfunction, praxis, extrapyramidal symptoms, myoclonus, neuropathology, prognosis
MeSH terms: Aged, Alzheimer Disease, Basal Ganglia Diseases, Humans, Middle Aged, Parkinson Disease, Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical Subtypes of Alzheimer’s Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks